By identifying your genetic profile, PlexusDx practitioners can proactively adjust your dose escalation timeline, recommend specific supportive supplements, or suggest alternative medications better suited to your biologypersonalizing your experience before discomfort occurs rather than managing it afterward
Other GLP-1 receptor agonists that are FDA-approved to treat type 2 diabetes and may lead to weight loss include: Dulaglutide (Trulicity) Exenatide (Bydureon) Lixisenatide (Adlyxin) Other forms of semaglutide (Ozempic and Rybelsus) Many diabetes medications and insulin reduce blood sugars but also contribute to weight gain
Studies using dynasore, an endocytosis inhibitor, demonstrate that blocking receptor internalization prevents BPC-157's angiogenic effects, confirming the importance of this pathway
Accelerate wound and injury healing related to muscles, tendons, ligaments, and joints to reduce acute/chronic pain and/or inflammation, increases mobility and range of motion, protects and heals digestive tract lining, and improves digestive function
Originally developed to help treat type 2 diabetes, these medications have also shown significant promise for helping with weight loss for folks with overweight or obesity
This framework is evidence-informed rather than a validated GLP-1specific guideline
